F. Novi

发表

Receptor crosstalk: haloperidol treatment enhances A2A adenosine receptor functioning in a transfected cell model

K. Klotz, M. Trincavelli, C. Martini, 2010, Purinergic Signalling.

Functional rescue of the inactive splice variant of the dopamine D3 receptor D3nf

M. Scarselli, G. Corsini, R. Maggio, 2003, Brain Research.

Deoxamuscaroneoxime derivatives as useful muscarinic agonists to explore the muscarinic subsite: demox, a modulator of orthosteric and allosteric sites at cardiac muscarinic M2 receptors.

G. Marucci, M. Buccioni, R. Maggio, 2002, Life sciences.

Optimization Sonication Time and Dilution Factor in Determining the Concentration of Endotoxin Challenge Vial with Kinetic Turbidimetric Method

E. Siska, S. Yati, F. Novi, 2021 .

Paired Activation of Two Components within Muscarinic M3 Receptor Dimers Is Required for Recruitment of β-Arrestin-1 to the Plasma Membrane*

F. Giorgi, G. Corsini, R. Maggio, 2005, Journal of Biological Chemistry.

The Paired Activation of the Two Components of the Muscarinic M3 Receptor Dimer Is Required for Induction of ERK1/2 Phosphorylation*

M. Scarselli, G. Corsini, R. Maggio, 2004, Journal of Biological Chemistry.

An Unusual Form of the Association Binding Kinetics ofN-[3H]Methylscopolamine to the Split Muscarinic M2trunk/M2tail Receptor

M. Scarselli, G. Corsini, R. Maggio, 2003, Journal of Pharmacology and Experimental Therapeutics.

S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], A Preferential Dopamine D3 versus D2 Receptor Antagonist and Potential Antipsychotic Agent: I. Receptor-Binding Profile and Functional Actions at G-Protein-Coupled Receptors

M. Millan, D. Cussac, A. Newman-Tancredi, 2008, Journal of Pharmacology and Experimental Therapeutics.

The impact of G‐protein‐coupled receptor hetero‐oligomerization on function and pharmacology

M. Scarselli, G. Corsini, R. Maggio, 2005, The FEBS journal.

D2/D3 Dopamine Receptor Heterodimers Exhibit Unique Functional Properties*

P. Sokoloff, Z. Vogel, R. Levenson, 2001, The Journal of Biological Chemistry.

Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formation.

M. Millan, M. Rossi, G. Corsini, 2008, Parkinsonism & related disorders.

Potent activation of dopamine D3/D2 heterodimers by the antiparkinsonian agents, S32504, pramipexole and ropinirole

M. Millan, M. Scarselli, G. Corsini, 2003, Journal of neurochemistry.

Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N‐desmethylclozapine and preclamol at dopamine D2L receptors are modified by co‐transfection of D3 receptors: potential role of heterodimer formation

M. Millan, G. Corsini, R. Maggio, 2007, Journal of neurochemistry.

Apomorphine, dopamine and phenylethylamine reduce the proportion of phosphorylated insulin receptor substrate 1.

M. Scarselli, G. Corsini, R. Maggio, 2001, European journal of pharmacology.